Keros Therapeutics, Inc. Made Headway
Keros Therapeutics, Inc. (KROS:NASDAQ) soared at $43.71, representing a gain of 32.5%. On Fri, Sep 24, 2021, KROS:NASDAQ hit a New 2-Week High of $33. The stock got featured on our News Catalysts scanner on Thu, Sep 02, 2021 at 08:44 AM in the 'MISCELLANEOUS' category. From Fri, Sep 10, 2021, the stock recorded 40.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Keros Therapeutics, Inc. (KROS:NASDAQ)
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Top 10 Gainers:
- PFTA (PFTA:NASDAQ), 100%
- Camber Energy, Inc. (CEI:NYSEMKT), 33.33%
- Keros Therapeutics, Inc. (KROS:NASDAQ), 32.45%
- Mediaco Holding Inc. (MDIA:NASDAQ), 32.42%
- New Concept Energy, Inc. (GBR:NYSEMKT), 31.36%
- AVTE (AVTE:NASDAQ), 24.45%
- ENGlobal Corporation (ENG:NASDAQ), 24.12%
- Southwestern Energy Company (SWN:NYSE), 21.99%
- Puhui Wealth Investment Management Co., Ltd. (PHCF:NASDAQ), 21.95%
- Naked Brand Group Limited (NAKD:NASDAQ), 21.8%